These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 11147718

  • 1. A prospective randomized study comparing endocrinological and clinical effects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis.
    Takeuchi H, Kobori H, Kikuchi I, Sato Y, Mitsuhashi N.
    J Obstet Gynaecol Res; 2000 Oct; 26(5):325-31. PubMed ID: 11147718
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of gonadotropin-releasing hormone agonists, nafarelin, buserelin, and leuprolide, on experimentally induced endometriosis in the rat.
    Mizutani T, Sakata M, Terakawa N.
    Int J Fertil Menopausal Stud; 1995 Oct; 40(2):106-11. PubMed ID: 7599657
    [Abstract] [Full Text] [Related]

  • 6. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.
    Parsanezhad ME, Azmoon M, Alborzi S, Rajaeefard A, Zarei A, Kazerooni T, Frank V, Schmidt EH.
    Fertil Steril; 2010 Jan; 93(1):192-8. PubMed ID: 19135657
    [Abstract] [Full Text] [Related]

  • 7. The efficacy and tolerability of short-term low-dose estrogen-only add-back therapy during post-operative GnRH agonist treatment for endometriosis.
    Kim NY, Ryoo U, Lee DY, Kim MJ, Yoon BK, Choi D.
    Eur J Obstet Gynecol Reprod Biol; 2011 Jan; 154(1):85-9. PubMed ID: 20832162
    [Abstract] [Full Text] [Related]

  • 8. Uterine ultrasonographic changes during endometriosis treatment: a comparison between levonorgestrel-releasing intrauterine devices and a gonadotropin-releasing hormone agonist.
    Manetta LA, de Paula Martins W, Rosa e Silva JC, de Sá Rosa e Silva AC, Nogueira AA, Ferriani RA.
    Ultrasound Med Biol; 2008 Dec; 34(12):1914-8. PubMed ID: 18597921
    [Abstract] [Full Text] [Related]

  • 9. Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy.
    Jasonni VM, D'Anna R, Mancuso A, Caruso C, Corrado F, Leonardi I.
    Acta Obstet Gynecol Scand; 2001 Oct; 80(10):956-8. PubMed ID: 11580742
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A randomized study comparing the side effects and hormonal status of triptorelin and leuprorelin following conservative laparoscopic surgery for ovarian endometriosis in Chinese women.
    Li Z, Zhang HY, Zhu YJ, Hu YJ, Qu PP.
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():164-8. PubMed ID: 25461372
    [Abstract] [Full Text] [Related]

  • 13. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
    Zhou J, Lei ZW, Lü JQ, Sun J, Xu XW.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Impact of different GnRH analogs in benign gynecological disorders related to their chemical structure, delivery systems and dose.
    Van Leusden HA.
    Gynecol Endocrinol; 1994 Sep; 8(3):215-22. PubMed ID: 7847108
    [Abstract] [Full Text] [Related]

  • 16. Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: a pilot study.
    Maheux R, Guilloteau C, Lemay A, Bastide A, Fazekas AT.
    Am J Obstet Gynecol; 1985 Aug 15; 152(8):1034-8. PubMed ID: 3927734
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin-releasing hormone agonist (leuprolide acetate).
    Mizutani T, Sugihara A, Nakamuro K, Terada N.
    J Clin Endocrinol Metab; 1998 Apr 15; 83(4):1253-5. PubMed ID: 9543151
    [Abstract] [Full Text] [Related]

  • 19. [Successful treatment of endometriosis in women with continuous subcutaneous infusion of gonadotropin-releasing hormone agonist (GnRH-A)].
    Masaoka K, Kitazawa M, Kumasaka T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Apr 15; 41(4):405-11. PubMed ID: 2501437
    [Abstract] [Full Text] [Related]

  • 20. Long-term administration of tibolone plus gonadotropin-releasing hormone agonist for the treatment of uterine leiomyomas: effectiveness and effects on vasomotor symptoms, bone mass, and lipid profiles.
    Palomba S, Affinito P, Di Carlo C, Bifulco G, Nappi C.
    Fertil Steril; 1999 Nov 15; 72(5):889-95. PubMed ID: 10560995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.